This educational activity is intended for oncologists, urologists, nurse practitioners, and other health care professionals involved in the management of patients with nccRCC.

Upon completion of the activity, participants should be able to:

• Recall the importance of accurate diagnosis and classification of nccRCC
• Compare and contrast clinical trial data on current and emerging uses of ICIs, TKIs, and combination ICI/TKI therapy
• Describe the rationale for combination therapies and treatment sequencing strategies in nccRCC
• Identify approaches for monitoring and managing AEs associated with ICIs and TKIs in nccRCC

This activity is jointly provided by The France Foundation and the Kidney Cancer Association.

In support of improving patient care, this activity has been planned and implemented by The France Foundation. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

CREDIT DESIGNATION

Physicians: The France Foundation designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: The France Foundation designates this activity for a maximum of 4.0 contact hours.

All other health care professionals completing this course will be issued a statement of participation.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

This activity is supported by independent medical education grants from Eisai, Exelixis, and Merck.

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.